Concentra Q4 revenue beats estimates

Overview

• Occupational health provider's preliminary Q4 revenue rose 15.9%, beating analyst expectations

• Net income for Q4 increased 58.7% yr/yr

• Company repurchased 1.1 mln shares totaling $22.4 mln

Outlook

• Concentra expects 2026 revenue between $2.25 bln and $2.35 bln

• Company forecasts 2026 adjusted EBITDA between $450 mln and $470 mln

• Concentra projects 2026 free cash flow between $200 mln and $225 mln

Result Drivers

• LOCATION EXPANSION - Concentra added over 300 locations in 2025, enhancing its service reach and value proposition, per CEO Keith Newton

• PATIENT VISITS - Increased patient visits contributed to revenue growth, with a 9.0% rise in visits per day in Q4 2025

• REVENUE PER VISIT - Revenue per visit increased by 3.1% to $149.63 in Q4 2025, supporting overall revenue growth

Key Details

Analyst Coverage

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

• The average consensus recommendation for the healthcare facilities & services peer group is "buy"

• Wall Street's median 12-month price target for Concentra Group Holdings Parent Inc is $28.50, about 31.6% above its January 27 closing price of $21.66

• The stock recently traded at 14 times the next 12-month earnings vs. a P/E of 14 three months ago

Press Release: ID:nBw655Thna

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.